Global Melanoma Market Research Report 2023

Report ID: 1988641 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Melanoma Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy
        1.2.3 Immunotherapy
        1.2.4 Targeted Therapy
        1.2.5 Radiation Therapy
    1.3 Market by Application
        1.3.1 Global Melanoma Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Melanoma Market Perspective (2017-2028)
    2.2 Melanoma Growth Trends by Region
        2.2.1 Melanoma Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Melanoma Historic Market Size by Region (2017-2022)
        2.2.3 Melanoma Forecasted Market Size by Region (2023-2028)
    2.3 Melanoma Market Dynamics
        2.3.1 Melanoma Industry Trends
        2.3.2 Melanoma Market Drivers
        2.3.3 Melanoma Market Challenges
        2.3.4 Melanoma Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Melanoma Players by Revenue
        3.1.1 Global Top Melanoma Players by Revenue (2017-2022)
        3.1.2 Global Melanoma Revenue Market Share by Players (2017-2022)
    3.2 Global Melanoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Melanoma Revenue
    3.4 Global Melanoma Market Concentration Ratio
        3.4.1 Global Melanoma Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Melanoma Revenue in 2021
    3.5 Melanoma Key Players Head office and Area Served
    3.6 Key Players Melanoma Product Solution and Service
    3.7 Date of Enter into Melanoma Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Breakdown Data by Type
    4.1 Global Melanoma Historic Market Size by Type (2017-2022)
    4.2 Global Melanoma Forecasted Market Size by Type (2023-2028)
5 Melanoma Breakdown Data by Application
    5.1 Global Melanoma Historic Market Size by Application (2017-2022)
    5.2 Global Melanoma Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Melanoma Market Size (2017-2028)
    6.2 North America Melanoma Market Size by Country (2017-2022)
    6.3 North America Melanoma Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Melanoma Market Size (2017-2028)
    7.2 Europe Melanoma Market Size by Country (2017-2022)
    7.3 Europe Melanoma Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Melanoma Market Size (2017-2028)
    8.2 Asia-Pacific Melanoma Market Size by Country (2017-2022)
    8.3 Asia-Pacific Melanoma Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Melanoma Market Size (2017-2028)
    9.2 Latin America Melanoma Market Size by Country (2017-2022)
    9.3 Latin America Melanoma Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Melanoma Market Size (2017-2028)
    10.2 Middle East & Africa Melanoma Market Size by Country (2017-2022)
    10.3 Middle East & Africa Melanoma Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Melanoma Introduction
        11.1.4 Amgen Revenue in Melanoma Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 Eristol-Mayers Squibb
        11.2.1 Eristol-Mayers Squibb Company Detail
        11.2.2 Eristol-Mayers Squibb Business Overview
        11.2.3 Eristol-Mayers Squibb Melanoma Introduction
        11.2.4 Eristol-Mayers Squibb Revenue in Melanoma Business (2017-2022)
        11.2.5 Eristol-Mayers Squibb Recent Development
    11.3 Eisai
        11.3.1 Eisai Company Detail
        11.3.2 Eisai Business Overview
        11.3.3 Eisai Melanoma Introduction
        11.3.4 Eisai Revenue in Melanoma Business (2017-2022)
        11.3.5 Eisai Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Melanoma Introduction
        11.4.4 Roche Revenue in Melanoma Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Genetech
        11.5.1 Genetech Company Detail
        11.5.2 Genetech Business Overview
        11.5.3 Genetech Melanoma Introduction
        11.5.4 Genetech Revenue in Melanoma Business (2017-2022)
        11.5.5 Genetech Recent Development
    11.6 Janssen Biotech
        11.6.1 Janssen Biotech Company Detail
        11.6.2 Janssen Biotech Business Overview
        11.6.3 Janssen Biotech Melanoma Introduction
        11.6.4 Janssen Biotech Revenue in Melanoma Business (2017-2022)
        11.6.5 Janssen Biotech Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Detail
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Melanoma Introduction
        11.7.4 Pfizer Revenue in Melanoma Business (2017-2022)
        11.7.5 Pfizer Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Melanoma Introduction
        11.8.4 Novartis Revenue in Melanoma Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Vical
        11.9.1 Vical Company Detail
        11.9.2 Vical Business Overview
        11.9.3 Vical Melanoma Introduction
        11.9.4 Vical Revenue in Melanoma Business (2017-2022)
        11.9.5 Vical Recent Development
    11.10 Ziopharm
        11.10.1 Ziopharm Company Detail
        11.10.2 Ziopharm Business Overview
        11.10.3 Ziopharm Melanoma Introduction
        11.10.4 Ziopharm Revenue in Melanoma Business (2017-2022)
        11.10.5 Ziopharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Melanoma Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Immunotherapy
    Table 4. Key Players of Targeted Therapy
    Table 5. Key Players of Radiation Therapy
    Table 6. Global Melanoma Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Melanoma Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Melanoma Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Melanoma Market Share by Region (2017-2022)
    Table 10. Global Melanoma Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Melanoma Market Share by Region (2023-2028)
    Table 12. Melanoma Market Trends
    Table 13. Melanoma Market Drivers
    Table 14. Melanoma Market Challenges
    Table 15. Melanoma Market Restraints
    Table 16. Global Melanoma Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Melanoma Market Share by Players (2017-2022)
    Table 18. Global Top Melanoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma as of 2021)
    Table 19. Ranking of Global Top Melanoma Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Melanoma Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Melanoma Product Solution and Service
    Table 23. Date of Enter into Melanoma Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Melanoma Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Melanoma Revenue Market Share by Type (2017-2022)
    Table 27. Global Melanoma Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Melanoma Revenue Market Share by Type (2023-2028)
    Table 29. Global Melanoma Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Melanoma Revenue Market Share by Application (2017-2022)
    Table 31. Global Melanoma Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Melanoma Revenue Market Share by Application (2023-2028)
    Table 33. North America Melanoma Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Melanoma Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Melanoma Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Melanoma Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Melanoma Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Melanoma Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Melanoma Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Melanoma Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Melanoma Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Melanoma Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Amgen Company Detail
    Table 44. Amgen Business Overview
    Table 45. Amgen Melanoma Product
    Table 46. Amgen Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 47. Amgen Recent Development
    Table 48. Eristol-Mayers Squibb Company Detail
    Table 49. Eristol-Mayers Squibb Business Overview
    Table 50. Eristol-Mayers Squibb Melanoma Product
    Table 51. Eristol-Mayers Squibb Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 52. Eristol-Mayers Squibb Recent Development
    Table 53. Eisai Company Detail
    Table 54. Eisai Business Overview
    Table 55. Eisai Melanoma Product
    Table 56. Eisai Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 57. Eisai Recent Development
    Table 58. Roche Company Detail
    Table 59. Roche Business Overview
    Table 60. Roche Melanoma Product
    Table 61. Roche Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 62. Roche Recent Development
    Table 63. Genetech Company Detail
    Table 64. Genetech Business Overview
    Table 65. Genetech Melanoma Product
    Table 66. Genetech Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 67. Genetech Recent Development
    Table 68. Janssen Biotech Company Detail
    Table 69. Janssen Biotech Business Overview
    Table 70. Janssen Biotech Melanoma Product
    Table 71. Janssen Biotech Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 72. Janssen Biotech Recent Development
    Table 73. Pfizer Company Detail
    Table 74. Pfizer Business Overview
    Table 75. Pfizer Melanoma Product
    Table 76. Pfizer Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 77. Pfizer Recent Development
    Table 78. Novartis Company Detail
    Table 79. Novartis Business Overview
    Table 80. Novartis Melanoma Product
    Table 81. Novartis Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Development
    Table 83. Vical Company Detail
    Table 84. Vical Business Overview
    Table 85. Vical Melanoma Product
    Table 86. Vical Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 87. Vical Recent Development
    Table 88. Ziopharm Company Detail
    Table 89. Ziopharm Business Overview
    Table 90. Ziopharm Melanoma Product
    Table 91. Ziopharm Revenue in Melanoma Business (2017-2022) & (US$ Million)
    Table 92. Ziopharm Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Melanoma Market Share by Type: 2021 VS 2028
    Figure 2. Chemotherapy Features
    Figure 3. Immunotherapy Features
    Figure 4. Targeted Therapy Features
    Figure 5. Radiation Therapy Features
    Figure 6. Global Melanoma Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Melanoma Report Years Considered
    Figure 11. Global Melanoma Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Melanoma Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Melanoma Market Share by Region: 2021 VS 2028
    Figure 14. Global Melanoma Market Share by Players in 2021
    Figure 15. Global Top Melanoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Melanoma Revenue in 2021
    Figure 17. North America Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Melanoma Market Share by Country (2017-2028)
    Figure 19. United States Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Melanoma Market Share by Country (2017-2028)
    Figure 23. Germany Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Melanoma Market Share by Region (2017-2028)
    Figure 31. China Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Melanoma Market Share by Country (2017-2028)
    Figure 39. Mexico Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Melanoma Market Share by Country (2017-2028)
    Figure 43. Turkey Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Melanoma Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Amgen Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 46. Eristol-Mayers Squibb Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 47. Eisai Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 48. Roche Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 49. Genetech Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 50. Janssen Biotech Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 51. Pfizer Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 52. Novartis Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 53. Vical Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 54. Ziopharm Revenue Growth Rate in Melanoma Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Eristol-Mayers Squibb
Eisai
Roche
Genetech
Janssen Biotech
Pfizer
Novartis
Vical
Ziopharm
Frequently Asked Questions
Melanoma report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Melanoma report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Melanoma report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Meniere’s Disease

Meniere’s Disease market is segmented by players, region (country), by Treatment and by Applica ... Read More

Menopause Treatment

Menopause Treatment market is segmented by players, region (country), by Type and by Application. ... Read More